NCT01736488View on ClinicalTrials.gov

Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2016

Conditions
Hypertension
Interventions
DRUG

Fimasartan

Fimasartan 60mg

DRUG

Atenolol

Atenolol 50mg

Trial Locations (4)

Unknown

Hallym University Medical Center, Anyang

Gachon University Gil Hospital, Incheon

Kangnam Severance Hospital, Seoul

120-752

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Severance Hospital

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT01736488 - Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients | Biotech Hunter | Biotech Hunter